| Q26748880 | A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma |
| Q34167517 | Absence of pancreatic intraepithelial neoplasia predicts poor survival after resection of pancreatic cancer. |
| Q30987695 | Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base |
| Q33820788 | Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us? |
| Q64280213 | Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I-II pancreatic cancer |
| Q55401908 | Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy. |
| Q38561432 | Artery first approach to pancreatoduodenectomy: current status. |
| Q37109795 | Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint |
| Q64064260 | Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients |
| Q33759924 | Diagnosis and management of pancreatic cancer. |
| Q38021384 | Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer |
| Q33780907 | Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study |
| Q92486885 | Exosomal markers (CD63 and CD9) expression and their prognostic significance using immunohistochemistry in patients with pancreatic ductal adenocarcinoma |
| Q35157803 | Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease. |
| Q36666622 | Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer |
| Q48047425 | Imaging findings of recurrent pancreatic cancer following resection. |
| Q38413842 | Individualized radiotherapy (iRT) concepts for locally advanced pancreatic cancer (LAPC): indications and prognostic factors |
| Q50041699 | Modified Appleby Procedure for Pancreatic Adenocarcinoma: Does Improved Neoadjuvant Therapy Warrant Such an Aggressive Approach? |
| Q57422493 | Molecular diagnostics in pancreatic cancer |
| Q35102975 | Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer. |
| Q42850230 | Postoperative Gemcitabine Alone and Concurrent with Radiation Therapy in Locally Advanced Pancreatic Carcinoma |
| Q39389689 | Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma |
| Q39453559 | Predictive and prognostic biomarkers in personalized gastrointestinal cancer treatment |
| Q88443486 | Primary Care Versus Oncology-Based Surveillance Following Adjuvant Chemotherapy in Resected Pancreatic Cancer |
| Q39717600 | Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer |
| Q39177574 | Prognostic impact of CA 19-9 on outcome after neoadjuvant chemoradiation in patients with locally advanced pancreatic cancer |
| Q59045167 | Safety Study of Photodynamic Therapy Using Talaporfin Sodium in the Pancreas and Surrounding Tissues in the Syrian Golden Hamster |
| Q55162030 | Stereotactic Body Radiation Therapy in the Management of Upper GI Malignancies. |
| Q35990105 | Surveillance of pancreatic cancer patients after surgical resection |
| Q53088925 | Survival estimates after pancreatoduodenectomy skewed by non-standardized histopathology reports. |
| Q57296505 | Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic Recurrence in Patients with Curatively Resected Pancreatic Adenocarcinoma |
| Q34635104 | The prognostic and predictive value of serum CA19.9 in pancreatic cancer |
| Q43272199 | Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT. |